COVID-19 in Pediatric Granulomatosis with Polyangiitis

Amir Saeed; Eslam Shorafa; Zahra Seratishirazi; Seyedenarjes Abootalebi

doi:10.3390/pediatric13010004

Pediatric Reports (Jan 2021)

COVID-19 in Pediatric Granulomatosis with Polyangiitis

Amir Saeed,
Eslam Shorafa,
Zahra Seratishirazi,
Seyedenarjes Abootalebi

Affiliations

Amir Saeed: Department of Pediatrics, Division of Intensive Care Unit, Shiraz University of Medical Sciences, Shiraz 71348, Iran
Eslam Shorafa: Department of Pediatrics, Division of Intensive Care Unit, Shiraz University of Medical Sciences, Shiraz 71348, Iran
Zahra Seratishirazi: Department of Pediatrics, Division of Intensive Care Unit, Shiraz University of Medical Sciences, Shiraz 71348, Iran
Seyedenarjes Abootalebi: Department of Pediatrics, Division of Intensive Care Unit, Shiraz University of Medical Sciences, Shiraz 71348, Iran

DOI: https://doi.org/10.3390/pediatric13010004
Journal volume & issue: Vol. 13, no. 1
pp. 31 – 34

Abstract

Read online

The confirmed cases with COVID-19 in children account for just 1% of the overall confirmed cases. Severe COVID-19 in children is rare. Case Presentation: Our patient was 16 years old with a severe case of COVID-19 and did not survive due to the presence of Granulomatosis with polyangiitis and being treated with immunosuppressive drugs. We used lopinavir, ritonavir, hydroxy chloroquine, intravenous immunoglobulin and continuous veno-venous hemodialysis for treatment. Conclusion: In this patient, an underlying disease and delayed admission to the hospital were two factors complicating his condition.

Published in Pediatric Reports

ISSN: 2036-749X (Print); 2036-7503 (Online)
Publisher: MDPI AG
Country of publisher: Switzerland
LCC subjects: Medicine: Pediatrics
Website: https://www.mdpi.com/journal/pediatrrep

About the journal

Abstract

Keywords